NTRB

Nutriband Inc. Common Stock

6.76

USD

-1.01

-13.00%

Sep 22, 15:59 UTC -4

Closed

Pre-Market

6.88

+0.12

+1.70%

Nutriband Inc. Common Stock Profile

About

Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company is engaged in developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. Nutriband Inc. is based in Orlando, United States.

Info & Links

CEO

Gareth Sheridan

Headquarters

121 South Orange Ave., Suite 1500
Orlando, FL 32801, UNITED STATES

Auditor

Sadler, Gibb & Associates, LLC

Share holders

Employees

Nutriband Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

83.57M

Enterprise Value

80.30M

Enterprise Value/EBITDA(ttm)

-11.70

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

61.08

Price to Book(mrq)

18.56

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

32.24%

Operating Margin(ttm)

-430.35%

Profit Margin(ttm)

-462.10%

Return on Equity(ttm)

-109.07%

Return on Invested Capital(ttm)

-102.51%

Return on Assets(ttm)

-95.54%

Income Statement

Revenue(ttm)

1.62M

Revenue Per Share(ttm)

0.13

Gross Profit(ttm)

536.10K

EBITDA(ttm)³

-6.86M

Net Income Available to Common(ttm)

-6.96M

Diluted EPS(ttm)

-0.53

Share Statistics

Beta (5Y Monthly)

2.03

52-Week Change

-7.27%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

12.16M

Dividend Yield

0.00%

Float⁴

5.81M

% Held by Insiders

52.21%

% Held by Institutions

19.70%

Balance Sheet

Total Cash(mrq)

3.42M

Total Cash Per Share(mrq)

0.28

Total Debt(mrq)

153.50K

Total Debt/Equity(mrq)

2.88%

Current Ratio(mrq)

4.21%

Quick Ratio(mrq)

4.02%

Book Value Per Share(mrq)

0.44

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.09

Free Cash Flow(ytd)

-1.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.